TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.0111402982852995	-4.49718626878227	12	10	0.0248138957816377	403	856	337876,10090,50515,51363,55790,9469,22856,166012,55454,79586	CHSY3,UST,CHST11,CHST15,CSGALNACT1,CHST3,CHSY1,CHST13,CSGALNACT2,CHPF
HUMAN_PWY4FS-8	phosphatidylglycerol biosynthesis II (non-plastidic)	0.0266575253634792	-3.62468379061486	18	13	0.032258064516129	403	856	8760,10555,55326,9489,56895,150763,254531,56894,10162,57678,129642,51099,1040	CDS2,AGPAT2,AGPAT5,PGS1,AGPAT4,GPAT2,LPCAT4,AGPAT3,LPCAT3,GPAM,MBOAT2,ABHD5,CDS1
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.0281076853553561	-3.57171223984619	13	10	0.0248138957816377	403	856	337876,10090,50515,51363,55790,9469,22856,166012,55454,79586	CHSY3,UST,CHST11,CHST15,CSGALNACT1,CHST3,CHSY1,CHST13,CSGALNACT2,CHPF
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.0281076853553561	-3.57171223984619	13	10	0.0248138957816377	403	856	55300,5298,5333,5336,10423,8394,5330,5305,55361,23396	PI4K2B,PI4KB,PLCD1,PLCG2,CDIPT,PIP5K1A,PLCB2,PIP4K2A,PI4K2A,PIP5K1C
HUMAN_COLANSYN-PWY	colanic acid building blocks biosynthesis	0.0361310503180141	-3.32060266372163	10	8	0.0198511166253102	403	856	5372,2584,7360,5373,7264,29926,7358,2582	PMM1,GALK1,UGP2,PMM2,TSTA3,GMPPA,UGDH,GALE
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	0.0361310503180141	-3.32060266372163	10	8	0.0198511166253102	403	856	55191,349565,64802,8564,23057,8942,23498,125061	NADSYN1,NMNAT3,NMNAT1,KMO,NMNAT2,KYNU,HAAO,AFMID
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis I	0.0424766034161753	-3.15880186249155	17	12	0.0297766749379653	403	856	8760,10555,55326,56895,150763,254531,56894,10162,57678,129642,51099,1040	CDS2,AGPAT2,AGPAT5,AGPAT4,GPAT2,LPCAT4,AGPAT3,LPCAT3,GPAM,MBOAT2,ABHD5,CDS1
HUMAN_PWY-4041	gamma-glutamyl cycle	0.044810667664687	-3.10530905039134	7	6	0.0148883374689826	403	856	2678,26873,55748,2687,54878,290	GGT1,OPLAH,CNDP2,GGT5,DPP8,ANPEP
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.048740354312162	-3.02124796137855	4	4	0.00992555831265509	403	856	349565,64802,23057,10135	NMNAT3,NMNAT1,NMNAT2,NAMPT
META_PWY-6569	chondroitin sulfate biosynthesis	0.0488004592011199	-3.02001555630829	19	13	0.032258064516129	403	856	337876,10090,50515,51363,55790,26229,9469,22856,166012,11285,27087,55454,79586	CHSY3,UST,CHST11,CHST15,CSGALNACT1,B3GAT3,CHST3,CHSY1,CHST13,B4GALT7,B3GAT1,CSGALNACT2,CHPF
HUMAN_LIPASYN-PWY	phospholipases	0.0514689845941047	-2.9667758936235	30	19	0.0471464019851117	403	856	89869,5333,81579,5338,50640,113026,151056,8399,5331,283748,5335,8605,255189,201164,5336,5337,122618,5330,123745	PLCZ1,PLCD1,PLA2G12A,PLD2,PNPLA8,PLCD3,PLB1,PLA2G10,PLCB3,PLA2G4D,PLCG1,PLA2G4C,PLA2G4F,PLD6,PLCG2,PLD1,PLD4,PLCB2,PLA2G4E
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.0644946820052244	-2.74117250811096	25	16	0.0397022332506203	403	856	8611,10555,55326,64748,346606,56895,150763,84649,254531,8612,56894,10162,57678,8694,129642,51099	PPAP2A,AGPAT2,AGPAT5,LPPR2,MOGAT3,AGPAT4,GPAT2,DGAT2,LPCAT4,PPAP2C,AGPAT3,LPCAT3,GPAM,DGAT1,MBOAT2,ABHD5
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.0663761349039434	-2.71241770120171	16	11	0.0272952853598015	403	856	337876,10090,51363,55790,26229,113189,22856,11285,27087,55454,79586	CHSY3,UST,CHST15,CSGALNACT1,B3GAT3,CHST14,CHSY1,B4GALT7,B3GAT1,CSGALNACT2,CHPF
META_PWY-6571	dermatan sulfate biosynthesis	0.0663761349039434	-2.71241770120171	16	11	0.0272952853598015	403	856	337876,10090,51363,55790,26229,113189,22856,11285,27087,55454,79586	CHSY3,UST,CHST15,CSGALNACT1,B3GAT3,CHST14,CHSY1,B4GALT7,B3GAT1,CSGALNACT2,CHPF
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.0808980760442705	-2.51456523710073	20	13	0.032258064516129	403	856	337876,10090,50515,51363,55790,26229,9469,22856,166012,11285,27087,55454,79586	CHSY3,UST,CHST11,CHST15,CSGALNACT1,B3GAT3,CHST3,CHSY1,CHST13,B4GALT7,B3GAT1,CSGALNACT2,CHPF
META_PWY6666-2	dopamine degradation	0.0835775953595113	-2.48197979290136	6	5	0.0124069478908189	403	856	4128,1312,445329,224,6818	MAOA,COMT,SULT1A4,ALDH3A2,SULT1A3
META_PWY-6566	chondroitin and dermatan biosynthesis	0.0835775953595113	-2.48197979290136	6	5	0.0124069478908189	403	856	337876,22856,55454,55790,79586	CHSY3,CHSY1,CSGALNACT2,CSGALNACT1,CHPF
HUMAN_PWY-6566	chondroitin and dermatan biosynthesis	0.0835775953595113	-2.48197979290136	6	5	0.0124069478908189	403	856	337876,22856,55454,55790,79586	CHSY3,CHSY1,CSGALNACT2,CSGALNACT1,CHPF
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.0910894203552674	-2.3959136136745	13	9	0.0223325062034739	403	856	3612,51763,3636,3632,54928,22876,8871,8867,3613	IMPA1,INPP5K,INPPL1,INPP5A,IMPAD1,INPP5F,SYNJ2,SYNJ1,IMPA2
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.0920911569598519	-2.38497635596746	24	15	0.0372208436724566	403	856	5335,55300,5298,89869,5333,5336,79837,113026,8394,10423,5330,5305,55361,23396,5331	PLCG1,PI4K2B,PI4KB,PLCZ1,PLCD1,PLCG2,PIP4K2C,PLCD3,PIP5K1A,CDIPT,PLCB2,PIP4K2A,PI4K2A,PIP5K1C,PLCB3
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.103938805570661	-2.26395296099508	3	3	0.00744416873449132	403	856	240,5743,4048	ALOX5,PTGS2,LTA4H
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.103938805570661	-2.26395296099508	3	3	0.00744416873449132	403	856	240,5743,4048	ALOX5,PTGS2,LTA4H
HUMAN_ARGASEDEG-PWY	arginine degradation I (arginase pathway)	0.103938805570661	-2.26395296099508	3	3	0.00744416873449132	403	856	8659,384,4942	ALDH4A1,ARG2,OAT
HUMAN_PWY-2301	myo-inositol biosynthesis	0.103938805570661	-2.26395296099508	3	3	0.00744416873449132	403	856	3612,54928,3613	IMPA1,IMPAD1,IMPA2
HUMAN_PWY-6309	tryptophan degradation via kynurenine	0.126736547494255	-2.06564477631109	10	7	0.0173697270471464	403	856	56267,883,125061,8564,130013,8942,23498	CCBL2,CCBL1,AFMID,KMO,ACMSD,KYNU,HAAO
META_PWY66-5	superpathway of cholesterol biosynthesis	0.128981046359221	-2.04808981286326	23	14	0.0347394540942928	403	856	4047,3157,3422,4598,6307,2224,6713,51478,1717,10654,9453,3930,2222,3156	LSS,HMGCS1,IDI1,MVK,MSMO1,FDPS,SQLE,HSD17B7,DHCR7,PMVK,GGPS1,LBR,FDFT1,HMGCR
HUMAN_PWY66-380	estradiol biosynthesis I	0.152399417708194	-1.88125045654927	5	4	0.00992555831265509	403	856	3292,1588,51478,1548	HSD17B1,CYP19A1,HSD17B7,CYP2A6
META_PWY-5667	CDP-diacylglycerol biosynthesis I	0.152399417708194	-1.88125045654927	5	4	0.00992555831265509	403	856	56894,10555,55326,56895	AGPAT3,AGPAT2,AGPAT5,AGPAT4
HUMAN_PWY66-375	leukotriene biosynthesis	0.152399417708194	-1.88125045654927	5	4	0.00992555831265509	403	856	240,1800,4056,4048	ALOX5,DPEP1,LTC4S,LTA4H
META_PWY66-375	leukotriene biosynthesis	0.152399417708194	-1.88125045654927	5	4	0.00992555831265509	403	856	240,1800,4056,4048	ALOX5,DPEP1,LTC4S,LTA4H
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	0.152399417708194	-1.88125045654927	5	4	0.00992555831265509	403	856	125061,8564,8942,23498	AFMID,KMO,KYNU,HAAO
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.152399417708194	-1.88125045654927	5	4	0.00992555831265509	403	856	55191,349565,64802,23057	NADSYN1,NMNAT3,NMNAT1,NMNAT2
HUMAN_PWY6666-2	dopamine degradation	0.180494914599023	-1.71205267557273	7	5	0.0124069478908189	403	856	4128,1312,445329,224,6818	MAOA,COMT,SULT1A4,ALDH3A2,SULT1A3
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.183638636068268	-1.69478538683264	26	15	0.0372208436724566	403	856	4047,3157,3422,4598,6307,2224,6713,7108,51478,1717,10654,9453,3930,2222,3156	LSS,HMGCS1,IDI1,MVK,MSMO1,FDPS,SQLE,TM7SF2,HSD17B7,DHCR7,PMVK,GGPS1,LBR,FDFT1,HMGCR
HUMAN_PWY-0	putrescine degradation III	0.198627559107421	-1.61632377009286	9	6	0.0148883374689826	403	856	4128,221,224,6303,218,222	MAOA,ALDH3B1,ALDH3A2,SAT1,ALDH3A1,ALDH3B2
META_PWY66-341	cholesterol biosynthesis I	0.211076770930038	-1.55553336841066	11	7	0.0173697270471464	403	856	6713,4047,51478,1717,6307,3930,2222	SQLE,LSS,HSD17B7,DHCR7,MSMO1,LBR,FDFT1
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.211076770930038	-1.55553336841066	11	7	0.0173697270471464	403	856	6713,4047,51478,1717,6307,3930,2222	SQLE,LSS,HSD17B7,DHCR7,MSMO1,LBR,FDFT1
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.211076770930038	-1.55553336841066	11	7	0.0173697270471464	403	856	3612,51763,8871,3632,8867,54928,3613	IMPA1,INPP5K,SYNJ2,INPP5A,SYNJ1,IMPAD1,IMPA2
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.211076770930038	-1.55553336841066	11	7	0.0173697270471464	403	856	6713,4047,51478,1717,6307,3930,2222	SQLE,LSS,HSD17B7,DHCR7,MSMO1,LBR,FDFT1
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.219954833588332	-1.51433305557831	13	8	0.0198511166253102	403	856	6713,7108,4047,51478,1717,6307,3930,2222	SQLE,TM7SF2,LSS,HSD17B7,DHCR7,MSMO1,LBR,FDFT1
HUMAN_PWY66-341	cholesterol biosynthesis I	0.219954833588332	-1.51433305557831	13	8	0.0198511166253102	403	856	6713,7108,4047,51478,1717,6307,3930,2222	SQLE,TM7SF2,LSS,HSD17B7,DHCR7,MSMO1,LBR,FDFT1
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.219954833588332	-1.51433305557831	13	8	0.0198511166253102	403	856	6713,7108,4047,51478,1717,6307,3930,2222	SQLE,TM7SF2,LSS,HSD17B7,DHCR7,MSMO1,LBR,FDFT1
META_PWY66-382	mineralocorticoid biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	1584,1585	CYP11B1,CYP11B2
META_PWY-6076	1,25-dihydroxyvitamin D3 biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	5447,120227	POR,CYP2R1
META_ALANINE-SYN2-PWY	alanine biosynthesis II	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	84706,2875	GPT2,GPT
META_PWY-6117	spermine and spermidine degradation I	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	54498,6303	SMOX,SAT1
META_PWY-5905	hypusine biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	83475,1725	DOHH,DHPS
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation I	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	8659,112817	ALDH4A1,HOGA1
HUMAN_PWY66-382	mineralocorticoid biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	1584,1585	CYP11B1,CYP11B2
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	80146,7358	UXS1,UGDH
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	80308,55312	FLAD1,RFK
HUMAN_PWY-5905	hypusine biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	83475,1725	DOHH,DHPS
HUMAN_SERDEG-PWY	L-serine degradation	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	113675,10993	SDSL,SDS
HUMAN_PWY-5525	D-glucuronate degradation I	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	51181,51084	DCXR,CRYL1
META_PWY0-1296	purine ribonucleosides degradation	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	4860,100	PNP,ADA
META_HYDROXYPRODEG-PWY	4-hydroxyproline degradation I	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	8659,112817	ALDH4A1,HOGA1
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	2805,137362	GOT1,GOT1L1
HUMAN_PWY-5386	methylglyoxal degradation I	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	2739,197257	GLO1,LDHD
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	471,10606	ATIC,PAICS
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	240,5743	ALOX5,PTGS2
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	240,5743	ALOX5,PTGS2
META_ALANINE-DEG3-PWY	alanine degradation III	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	84706,2875	GPT2,GPT
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	471,10606	ATIC,PAICS
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	6713,2222	SQLE,FDFT1
HUMAN_PWY-46	putrescine biosynthesis III	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	4953,113451	ODC1,ADC
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	240,5743	ALOX5,PTGS2
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	1588,51478	CYP19A1,HSD17B7
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage pathway	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	55163,8566	PNPO,PDXK
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	4860,100	PNP,ADA
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	240,5743	ALOX5,PTGS2
META_PWY-5670	epoxysqualene biosynthesis	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	6713,2222	SQLE,FDFT1
META_PWY-6307	tryptophan degradation X (mammalian, via tryptamine)	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	224,1644	ALDH3A2,DDC
META_PROUT-PWY	proline degradation	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	8659,5625	ALDH4A1,PRODH
HUMAN_PWY-7306	estradiol biosynthesis II	0.221355959993365	-1.50798319451314	2	2	0.00496277915632754	403	856	1588,1548	CYP19A1,CYP2A6
META_PWY66-400	glycolysis VI (metazoan)	0.23122295787148	-1.46437284836163	17	10	0.0248138957816377	403	856	2645,5230,669,5211,5313,226,5224,3098,5315,3101	GCK,PGK1,BPGM,PFKL,PKLR,ALDOA,PGAM2,HK1,PKM,HK3
HUMAN_PWY66-400	glycolysis	0.23122295787148	-1.46437284836163	17	10	0.0248138957816377	403	856	2645,5230,669,5211,5313,226,5224,3098,5315,3101	GCK,PGK1,BPGM,PFKL,PKLR,ALDOA,PGAM2,HK1,PKM,HK3
META_PWY-6368	3-phosphoinositide degradation	0.234773848474988	-1.44913257510601	19	11	0.0272952853598015	403	856	51763,56623,3636,3631,3635,90809,8821,22908,22876,8871,8867	INPP5K,INPP5E,INPPL1,INPP4A,INPP5D,TMEM55B,INPP4B,SACM1L,INPP5F,SYNJ2,SYNJ1
META_PWY-6352	3-phosphoinositide biosynthesis	0.240624556044338	-1.42451741895233	25	14	0.0347394540942928	403	856	55300,5298,23533,5296,5295,5290,8503,22908,5287,10423,8394,5286,55361,23396	PI4K2B,PI4KB,PIK3R5,PIK3R2,PIK3R1,PIK3CA,PIK3R3,SACM1L,PIK3C2B,CDIPT,PIP5K1A,PIK3C2A,PI4K2A,PIP5K1C
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	3422,9453,2224	IDI1,GGPS1,FDPS
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	10090,113189,51363	UST,CHST14,CHST15
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	3422,9453,2224	IDI1,GGPS1,FDPS
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	5372,5373,29926	PMM1,PMM2,GMPPA
HUMAN_PWY-5481	pyruvate fermentation to lactate	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	92483,3939,3945	LDHAL6B,LDHA,LDHB
META_ARGASEDEG-PWY	arginine degradation I (arginase pathway)	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	384,8659,4942	ARG2,ALDH4A1,OAT
HUMAN_PWY0-1182	trehalose degradation II (trehalase)	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	80201,11181,2645	HKDC1,TREH,GCK
META_PWY66-162	ethanol degradation IV	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	847,55902,224	CAT,ACSS2,ALDH3A2
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	9997,1890,7378	SCO2,TYMP,UPP1
HUMAN_ARG-PRO-PWY	arginine degradation VI (arginase 2 pathway)	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	384,4942,65263	ARG2,OAT,PYCRL
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	10090,113189,51363	UST,CHST14,CHST15
HUMAN_PWY66-11	BMP Signalling Pathway	0.269534159345804	-1.31106014584598	4	3	0.00744416873449132	403	856	7323,4089,6497	UBE2D3,SMAD4,SKI
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	2531,123099,10715,9517	KDSR,DEGS2,CERS1,SPTLC2
META_ARGININE-SYN4-PWY	arginine biosynthesis IV	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	445,4942,2747,435	ASS1,OAT,GLUD2,ASL
META_PWY-6309	tryptophan degradation XI (mammalian, via kynurenine)	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	883,8564,130013,23498	CCBL1,KMO,ACMSD,HAAO
META_PWY3DJ-12	ceramide de novo biosynthesis	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	2531,123099,10715,9517	KDSR,DEGS2,CERS1,SPTLC2
HUMAN_PWY-6074	zymosterol biosynthesis	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	7108,51478,6307,3930	TM7SF2,HSD17B7,MSMO1,LBR
HUMAN_PWY66-162	ethanol degradation IV	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	847,55902,224,7306	CAT,ACSS2,ALDH3A2,TYRP1
HUMAN_ARGININE-SYN4-PWY	arginine biosynthesis IV	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	445,4942,2747,435	ASS1,OAT,GLUD2,ASL
HUMAN_PWY-2201	folate transformations	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	10797,400410,6470,4548	MTHFD2,ST20,SHMT1,MTR
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.290043062409312	-1.23772587595873	6	4	0.00992555831265509	403	856	2531,123099,10715,9517	KDSR,DEGS2,CERS1,SPTLC2
META_PWY-7305	superpathway of steroid hormone biosynthesis	0.300623684461087	-1.2018960141447	8	5	0.0124069478908189	403	856	6716,1588,51478,1584,1585	SRD5A2,CYP19A1,HSD17B7,CYP11B1,CYP11B2
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	0.300623684461087	-1.2018960141447	8	5	0.0124069478908189	403	856	25796,6120,22934,5226,7086	PGLS,RPE,RPIA,PGD,TKT
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	0.300623684461087	-1.2018960141447	8	5	0.0124069478908189	403	856	80201,2645,6675,10007,2582	HKDC1,GCK,UAP1,GNPDA1,GALE
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	0.306464076527996	-1.18265473593012	10	6	0.0148883374689826	403	856	2639,125061,8564,8942,130013,23498	GCDH,AFMID,KMO,KYNU,ACMSD,HAAO
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.308525973753426	-1.17594924549059	67	34	0.0843672456575682	403	856	3707,3636,89869,90809,3635,113026,10423,8867,5305,117283,23396,5331,51763,64768,5298,23533,3632,5336,5296,5290,8503,8871,5330,5333,9807,5295,79837,8394,5286,55361,5335,55300,22908,5287	ITPKB,INPPL1,PLCZ1,TMEM55B,INPP5D,PLCD3,CDIPT,SYNJ1,PIP4K2A,IP6K3,PIP5K1C,PLCB3,INPP5K,IPPK,PI4KB,PIK3R5,INPP5A,PLCG2,PIK3R2,PIK3CA,PIK3R3,SYNJ2,PLCB2,PLCD1,IP6K1,PIK3R1,PIP4K2C,PIP5K1A,PIK3C2A,PI4K2A,PLCG1,PI4K2B,SACM1L,PIK3C2B
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.30966999307264	-1.17224808700183	12	7	0.0173697270471464	403	856	3157,3422,4598,9453,10654,2224,3156	HMGCS1,IDI1,MVK,GGPS1,PMVK,FDPS,HMGCR
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.310972321520582	-1.16805136908959	20	11	0.0272952853598015	403	856	3612,51763,3707,3636,3632,54928,3635,22876,8871,8867,3613	IMPA1,INPP5K,ITPKB,INPPL1,INPP5A,IMPAD1,INPP5D,INPP5F,SYNJ2,SYNJ1,IMPA2
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.311645831526727	-1.16588789131255	18	10	0.0248138957816377	403	856	5335,89869,5333,90809,5336,79837,113026,5330,5305,5331	PLCG1,PLCZ1,PLCD1,TMEM55B,PLCG2,PIP4K2C,PLCD3,PLCB2,PIP4K2A,PLCB3
HUMAN_PWY66-405	tryptophan utilization II	0.373389986877913	-0.98513186430822	29	15	0.0372208436724566	403	856	55191,349565,64802,8564,23057,130013,8942,23498,4128,445329,2639,125061,224,6818,1644	NADSYN1,NMNAT3,NMNAT1,KMO,NMNAT2,ACMSD,KYNU,HAAO,MAOA,SULT1A4,GCDH,AFMID,ALDH3A2,SULT1A3,DDC
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.377756938574337	-0.973504309832959	27	14	0.0347394540942928	403	856	55300,5298,23533,5295,5296,5290,22908,8503,5287,8394,10423,5286,55361,23396	PI4K2B,PI4KB,PIK3R5,PIK3R1,PIK3R2,PIK3CA,SACM1L,PIK3R3,PIK3C2B,PIP5K1A,CDIPT,PIK3C2A,PI4K2A,PIP5K1C
META_PWY-6564	heparan sulfate biosynthesis	0.386995669982153	-0.949341774691557	23	12	0.0297766749379653	403	856	9394,8509,2134,9957,26229,2131,9953,11285,27087,3340,9955,266722	HS6ST1,NDST2,EXTL1,HS3ST1,B3GAT3,EXT1,HS3ST3B1,B4GALT7,B3GAT1,NDST1,HS3ST3A1,HS6ST3
HUMAN_PWY-6368	3-phosphoinositide degradation	0.391910412506913	-0.936722004833993	21	11	0.0272952853598015	403	856	51763,56623,3636,3631,3635,90809,8821,22908,22876,8871,8867	INPP5K,INPP5E,INPPL1,INPP4A,INPP5D,TMEM55B,INPP4B,SACM1L,INPP5F,SYNJ2,SYNJ1
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.397059146028788	-0.923670026951455	19	10	0.0248138957816377	403	856	3612,51763,3707,3636,3632,54928,3635,8871,8867,3613	IMPA1,INPP5K,ITPKB,INPPL1,INPP5A,IMPAD1,INPP5D,SYNJ2,SYNJ1,IMPA2
META_PWY-6558	heparan sulfate biosynthesis (late stages)	0.402478772582414	-0.910112922439943	17	9	0.0223325062034739	403	856	9394,8509,2134,9957,2131,9953,3340,266722,9955	HS6ST1,NDST2,EXTL1,HS3ST1,EXT1,HS3ST3B1,NDST1,HS6ST3,HS3ST3A1
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	0.408217053788759	-0.895956251456632	15	8	0.0198511166253102	403	856	29922,2987,50484,8382,6241,8833,3614,4832	NME7,GUK1,RRM2B,NME5,RRM2,GMPS,IMPDH1,NME3
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.408217053788759	-0.895956251456632	15	8	0.0198511166253102	403	856	51763,3707,64768,3636,3632,3635,8871,8867	INPP5K,ITPKB,IPPK,INPPL1,INPP5A,INPP5D,SYNJ2,SYNJ1
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.408217053788759	-0.895956251456632	15	8	0.0198511166253102	403	856	51763,3707,64768,3636,3632,3635,8871,8867	INPP5K,ITPKB,IPPK,INPPL1,INPP5A,INPP5D,SYNJ2,SYNJ1
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.408217053788759	-0.895956251456632	15	8	0.0198511166253102	403	856	6241,1635,84284,1841,29922,50484,4832,8382	RRM2,DCTD,NTPCR,DTYMK,NME7,RRM2B,NME3,NME5
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	0.414337679138584	-0.881073987525392	13	7	0.0173697270471464	403	856	6716,3292,1588,51478,1584,1548,1585	SRD5A2,HSD17B1,CYP19A1,HSD17B7,CYP11B1,CYP2A6,CYP11B2
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.414337679138584	-0.881073987525392	13	7	0.0173697270471464	403	856	3157,3422,4598,9453,10654,2224,3156	HMGCS1,IDI1,MVK,GGPS1,PMVK,FDPS,HMGCR
META_PWY-6861	the visual cycle I (vertebrates)	0.414337679138584	-0.881073987525392	13	7	0.0173697270471464	403	856	5948,5949,9249,9227,5959,157506,6017	RBP2,RBP3,DHRS3,LRAT,RDH5,RDH10,RLBP1
HUMAN_PWY-3561	choline biosynthesis III	0.42811884115484	-0.848354455692853	9	5	0.0124069478908189	403	856	5338,5337,56994,122618,201164	PLD2,PLD1,CHPT1,PLD4,PLD6
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.42811884115484	-0.848354455692853	9	5	0.0124069478908189	403	856	5330,5333,5305,90809,5336	PLCB2,PLCD1,PIP4K2A,TMEM55B,PLCG2
HUMAN_PWY66-374	C20 prostanoid biosynthesis	0.436107259492121	-0.82986705787866	7	4	0.00992555831265509	403	856	5743,5742,5730,6916	PTGS2,PTGS1,PTGDS,TBXAS1
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	0.436107259492121	-0.82986705787866	7	4	0.00992555831265509	403	856	4860,51251,100,4907	PNP,NT5C3A,ADA,NT5E
META_PWY-6313	serotonin degradation	0.436107259492121	-0.82986705787866	7	4	0.00992555831265509	403	856	4128,445329,224,6818	MAOA,SULT1A4,ALDH3A2,SULT1A3
META_PWY66-374	C20 prostanoid biosynthesis	0.436107259492121	-0.82986705787866	7	4	0.00992555831265509	403	856	5742,5743,5730,6916	PTGS1,PTGS2,PTGDS,TBXAS1
HUMAN_PWY-4983	citrulline-nitric oxide cycle	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	445,4843,435	ASS1,NOS2,ASL
HUMAN_DETOX1-PWY	superoxide radicals degradation	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	847,6647,7306	CAT,SOD1,TYRP1
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	4860,100,4907	PNP,ADA,NT5E
META_PWY-6074	zymosterol biosynthesis	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	51478,6307,3930	HSD17B7,MSMO1,LBR
META_PWY-4983	citrulline-nitric oxide cycle	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	445,4843,435	ASS1,NOS2,ASL
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	6120,22934,7086	RPE,RPIA,TKT
HUMAN_PWY-4984	urea cycle	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	445,384,435	ASS1,ARG2,ASL
META_PWY-4081	glutathione redox reactions I	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	2878,2876,2879	GPX3,GPX1,GPX4
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.445236271806645	-0.809150189838749	5	3	0.00744416873449132	403	856	3614,4860,4907	IMPDH1,PNP,NT5E
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	79947,79644	DHDDS,SRD5A3
META_LEU-DEG2-PWY	leucine degradation I	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	64087,56922	MCCC2,MCCC1
META_PWY-6609	adenine and adenosine salvage III	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	4860,100	PNP,ADA
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	4967,1743	OGDH,DLST
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	2618,5471	GART,PPAT
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	79152,224	FA2H,ALDH3A2
HUMAN_GLYCINE-SYN2-PWY-1	glycine biosynthesis II	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	275,2731	AMT,GLDC
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	9415,2180	FADS2,ACSL1
META_GLYCLEAV-PWY	glycine cleavage	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	275,2731	AMT,GLDC
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	2618,5471	GART,PPAT
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	4967,1743	OGDH,DLST
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	84284,1503	NTPCR,CTPS1
META_PWY-7193	pyrimidine ribonucleosides salvage I	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	83549,7371	UCK1,UCK2
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	6723,4953	SRM,ODC1
META_PWY-7049	eicosapentaenoate biosynthesis II (metazoa)	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	9415,2180	FADS2,ACSL1
HUMAN_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	25796,5226	PGLS,PGD
HUMAN_PWY-6609	adenine and adenosine salvage III	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	4860,100	PNP,ADA
HUMAN_GLUCOSE1PMETAB-PWY	glucose and glucose-1-phosphate degradation	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	80201,2645	HKDC1,GCK
HUMAN_LYSINE-DEG1-PWY	lysine degradation II	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	501,51097	ALDH7A1,SCCPDH
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	275,2731	AMT,GLDC
HUMAN_PWY-5661	GDP-glucose biosynthesis	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	80201,2645	HKDC1,GCK
META_PWY-5505	glutamate and glutamine biosynthesis	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	2747,2752	GLUD2,GLUL
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	275,2731	AMT,GLDC
META_PWY-7185	UTP and CTP dephosphorylation I	0.456190268837993	-0.784845300271253	3	2	0.00496277915632754	403	856	84284,1503	NTPCR,CTPS1
HUMAN_PWY-6564	heparan sulfate biosynthesis	0.457463287442274	-0.782058643514263	26	13	0.032258064516129	403	856	9394,9951,8509,2134,9957,26229,9953,2131,11285,27087,3340,9955,266722	HS6ST1,HS3ST4,NDST2,EXTL1,HS3ST1,B3GAT3,HS3ST3B1,EXT1,B4GALT7,B3GAT1,NDST1,HS3ST3A1,HS6ST3
META_PWY-6292	cysteine biosynthesis III (mammalia)	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	875	CBS
HUMAN_PWY-6133	(S)-reticuline biosynthesis II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	7299	TYR
HUMAN_P121-PWY	adenine and adenosine salvage I	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	353	APRT
META_ASPARTATESYN-PWY	aspartate biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2805	GOT1
META_PWY-5686	UMP biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	790	CAD
HUMAN_PWY-5148	acyl-CoA hydrolysis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	23597	ACOT9
HUMAN_PWY-6399	melatonin degradation II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	4128	MAOA
HUMAN_GLYCGREAT-PWY	glycine degradation (creatine biosynthesis)	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2593	GAMT
META_PWY-5966	fatty acid biosynthesis initiation II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2194	FASN
META_PWY-46	putrescine biosynthesis III	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	4953	ODC1
HUMAN_PWY-6898	thiamin salvage III	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	27010	TPK1
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2582	GALE
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	130013	ACMSD
HUMAN_PWY-6132	lanosterol biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	4047	LSS
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	9453	GGPS1
META_PWY-5326	sulfite oxidation IV	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	6821	SUOX
META_PWY66-389	phytol degradation	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	224	ALDH3A2
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2582	GALE
META_PWY-6938	NADH repair	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	128240	APOA1BP
HUMAN_PROUT-PWY	proline degradation	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	8659	ALDH4A1
META_PWY-6502	oxidized GTP and dGTP detoxification	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	4521	NUDT1
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	9453	GGPS1
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	875	CBS
HUMAN_PWY-5326	sulfite oxidation IV	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	6821	SUOX
HUMAN_ALANINE-SYN2-PWY	alanine biosynthesis II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2875	GPT
META_GLNSYN-PWY	glutamine biosynthesis I	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2752	GLUL
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	1509	CTSD
META_PWY-7306	estradiol biosynthesis II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	1588	CYP19A1
META_PWY-6619	adenine and adenosine salvage VI	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	132	ADK
HUMAN_PWY-7179	purine deoxyribonucleosides degradation	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	100	ADA
HUMAN_PWY66-366	flavin biosynthesis IV (mammalian)	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	80308	FLAD1
META_PWY-7344	UDP-D-galactose biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2582	GALE
HUMAN_PWY-6938	NADH repair	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	128240	APOA1BP
HUMAN_PWY-5389	methylthiopropionate biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	55256	ADI1
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	6723	SRM
META_PWY-6132	lanosterol biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	4047	LSS
META_PWY6666-1	anandamide degradation	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2166	FAAH
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	130013	ACMSD
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	7264	TSTA3
HUMAN_PWY-5269	cardiolipin biosynthesis II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	9489	PGS1
META_PWY-6481	L-dopachrome biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	7299	TYR
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	197257	LDHD
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	4521	NUDT1
META_PWY0-1313	acetate conversion to acetyl-CoA	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	55902	ACSS2
HUMAN_ALANINE-DEG3-PWY	alanine degradation	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2875	GPT
HUMAN_GLNSYN-PWY	glutamine biosynthesis I	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	2752	GLUL
META_PWY-5269	cardiolipin biosynthesis II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	9489	PGS1
HUMAN_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	47	ACLY
HUMAN_PWY66-389	phytol degradation	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	224	ALDH3A2
HUMAN_PWY-6481	L-dopachrome biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	7299	TYR
META_PWY-6012	acyl carrier protein metabolism	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	60496	AASDHPPT
META_PWY-6241	thyroid hormone biosynthesis	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	1509	CTSD
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	197257	LDHD
HUMAN_PWY-6619	adenine and adenosine salvage II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	132	ADK
HUMAN_PWY-6334	L-dopa degradation	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	1312	COMT
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	6723	SRM
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis I	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	440	ASNS
META_PWY-6133	(S)-reticuline biosynthesis II	0.470794392523605	-0.753333814194548	1	1	0.00248138957816377	403	856	7299	TYR
HUMAN_PWY66-409	purine nucleotide salvage	0.473677451528164	-0.747228670928122	41	20	0.0496277915632754	403	856	204,2987,4860,8382,6241,521,353,122622,4832,100,159,29922,50484,10476,3614,8833,498,267020,158067,132	AK2,GUK1,PNP,NME5,RRM2,ATP5I,APRT,ADSSL1,NME3,ADA,ADSS,NME7,RRM2B,ATP5H,IMPDH1,GMPS,ATP5A1,ATP5L2,AK8,ADK
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.473677451528164	-0.747228670928122	41	20	0.0496277915632754	403	856	204,2987,5471,8382,6241,521,122622,4832,159,2618,29922,50484,10606,10476,471,3614,8833,498,267020,158067	AK2,GUK1,PPAT,NME5,RRM2,ATP5I,ADSSL1,NME3,ADSS,GART,NME7,RRM2B,PAICS,ATP5H,ATIC,IMPDH1,GMPS,ATP5A1,ATP5L2,AK8
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	0.48314597053861	-0.727436454551708	20	10	0.0248138957816377	403	856	9394,9951,8509,2134,9957,2131,9953,3340,9955,266722	HS6ST1,HS3ST4,NDST2,EXTL1,HS3ST1,EXT1,HS3ST3B1,NDST1,HS3ST3A1,HS6ST3
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	0.517409010053947	-0.658921595284524	14	7	0.0173697270471464	403	856	3614,6241,2618,2987,5471,471,10606	IMPDH1,RRM2,GART,GUK1,PPAT,ATIC,PAICS
META_PWY-5004	superpathway of citrulline metabolism	0.532187693423269	-0.630759044675717	12	6	0.0148883374689826	403	856	445,384,5625,4942,4843,435	ASS1,ARG2,PRODH,OAT,NOS2,ASL
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.532187693423269	-0.630759044675717	12	6	0.0148883374689826	403	856	3614,8833,29922,2987,4832,8382	IMPDH1,GMPS,NME7,GUK1,NME3,NME5
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.532187693423269	-0.630759044675717	12	6	0.0148883374689826	403	856	29922,2987,1716,1633,4832,8382	NME7,GUK1,DGUOK,DCK,NME3,NME5
HUMAN_PWY-6353	purine nucleotides degradation	0.549773605782938	-0.598248711346	10	5	0.0124069478908189	403	856	3614,4860,51251,100,4907	IMPDH1,PNP,NT5C3A,ADA,NT5E
META_PWY-922	mevalonate pathway I	0.549773605782938	-0.598248711346	10	5	0.0124069478908189	403	856	3157,3422,4598,10654,3156	HMGCS1,IDI1,MVK,PMVK,HMGCR
HUMAN_PWY-7049	eicosapentaenoate biosynthesis II (metazoa)	0.549773605782938	-0.598248711346	10	5	0.0124069478908189	403	856	51703,9415,2180,2181,142827	ACSL5,FADS2,ACSL1,ACSL3,C10orf129
META_PWY-5328	superpathway of methionine degradation	0.549773605782938	-0.598248711346	10	5	0.0124069478908189	403	856	875,2805,6821,594,4548	CBS,GOT1,SUOX,BCKDHB,MTR
HUMAN_PWY-3661	glycine betaine degradation	0.571590834524867	-0.559331867826035	8	4	0.00992555831265509	403	856	1757,113675,6470,10993	SARDH,SDSL,SHMT1,SDS
META_ANAEROFRUCAT-PWY	homolactic fermentation	0.59541253852269	-0.518500771632124	17	8	0.0198511166253102	403	856	5224,2645,5315,5211,5230,669,5313,226	PGAM2,GCK,PKM,PFKL,PGK1,BPGM,PKLR,ALDOA
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	9997,1890,7378	SCO2,TYMP,UPP1
META_CITRULBIO-PWY	citrulline biosynthesis	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	384,5625,4942	ARG2,PRODH,OAT
HUMAN_PWY-6430	thymine degradation	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	10570,1807,1809	DPYSL4,DPYS,DPYSL3
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	3795,226,6476	KHK,ALDOA,SI
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	55224,85465,55500	ETNK2,EPT1,ETNK1
HUMAN_PWY-3982	uracil degradation I (reductive)	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	10570,1807,1809	DPYSL4,DPYS,DPYSL3
HUMAN_PWY-5143	fatty acid activation	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	51703,2180,2181	ACSL5,ACSL1,ACSL3
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	11285,27087,26229	B4GALT7,B3GAT1,B3GAT3
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	3614,4860,4907	IMPDH1,PNP,NT5E
HUMAN_PWY66-373	sucrose degradation V (mammalian)	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	3795,226,6476	KHK,ALDOA,SI
META_PWY-4984	urea cycle	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	445,384,435	ASS1,ARG2,ASL
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.600429481207445	-0.510110077817656	6	3	0.00744416873449132	403	856	11285,27087,26229	B4GALT7,B3GAT1,B3GAT3
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	0.612951971787841	-0.489468695564276	15	7	0.0173697270471464	403	856	6241,84284,1841,29922,50484,4832,8382	RRM2,NTPCR,DTYMK,NME7,RRM2B,NME3,NME5
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.612951971787841	-0.489468695564276	15	7	0.0173697270471464	403	856	5948,5949,9249,9227,5959,157506,6017	RBP2,RBP3,DHRS3,LRAT,RDH5,RDH10,RLBP1
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.612951971787841	-0.489468695564276	15	7	0.0173697270471464	403	856	51763,3707,8871,3636,3632,8867,3635	INPP5K,ITPKB,SYNJ2,INPPL1,INPP5A,SYNJ1,INPP5D
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.612951971787841	-0.489468695564276	15	7	0.0173697270471464	403	856	51763,3707,8871,3636,3632,8867,3635	INPP5K,ITPKB,SYNJ2,INPPL1,INPP5A,SYNJ1,INPP5D
HUMAN_PWY66-407	conversion of glucose to acetyl CoA and entry into the TCA cycle	0.620282601331073	-0.477580096193679	37	17	0.0421836228287841	403	856	5160,669,6391,5313,2271,5161,4967,5315,1743,6390,2645,5211,5230,226,5224,3098,3101	PDHA1,BPGM,SDHC,PKLR,FH,PDHA2,OGDH,PKM,DLST,SDHB,GCK,PFKL,PGK1,ALDOA,PGAM2,HK1,HK3
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.633201991382723	-0.45696580602962	13	6	0.0148883374689826	403	856	51703,3295,2180,30,2181,23305	ACSL5,HSD17B4,ACSL1,ACAA1,ACSL3,ACSL6
HUMAN_PWY-5004	superpathway of citrulline metabolism	0.633201991382723	-0.45696580602962	13	6	0.0148883374689826	403	856	445,384,440,4942,4843,435	ASS1,ARG2,ASNS,OAT,NOS2,ASL
HUMAN_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.633201991382723	-0.45696580602962	13	6	0.0148883374689826	403	856	51703,3295,2180,30,2181,23305	ACSL5,HSD17B4,ACSL1,ACAA1,ACSL3,ACSL6
META_PWY-6823	molybdenum cofactor biosynthesis	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	27304,10243	MOCS3,GPHN
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	3145,210	HMBS,ALAD
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	5224,669	PGAM2,BPGM
HUMAN_PWY-6317	galactose degradation I (Leloir pathway)	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	2584,2582	GALK1,GALE
HUMAN_PWY66-408	glycine biosynthesis	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	189,6470	AGXT,SHMT1
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	83549,7371	UCK1,UCK2
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	5224,669	PGAM2,BPGM
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	1152,1159	CKB,CKMT1B
HUMAN_PWY-2161	folate polyglutamylation	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	6470,2356	SHMT1,FPGS
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	8564,23498	KMO,HAAO
META_PWY66-21	ethanol degradation II	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	55902,224	ACSS2,ALDH3A2
HUMAN_PWY-6292	cysteine biosynthesis III (mammalia)	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	27430,875	MAT2B,CBS
META_PWY-6158	creatine-phosphate biosynthesis	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	1152,1159	CKB,CKMT1B
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	2632,2997	GBE1,GYS1
META_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	8564,23498	KMO,HAAO
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation I	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	58478,55256	ENOPH1,ADI1
HUMAN_PWY-4981	proline biosynthesis II (from arginine)	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	4942,65263	OAT,PYCRL
META_PWY66-161	ethanol degradation III (oxidative)	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	55902,224	ACSS2,ALDH3A2
HUMAN_PWY-5874	heme degradation	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	3162,645	HMOX1,BLVRB
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	3145,210	HMBS,ALAD
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	2941,2950	GSTA4,GSTP1
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	27304,10243	MOCS3,GPHN
HUMAN_PWY-6307	tryptophan degradation X (mammalian, via tryptamine)	0.642846378335989	-0.441849497229919	4	2	0.00496277915632754	403	856	224,1644	ALDH3A2,DDC
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.657144241231329	-0.419851739340894	11	5	0.0124069478908189	403	856	6241,29922,50484,4832,8382	RRM2,NME7,RRM2B,NME3,NME5
HUMAN_PWY-5972	stearate biosynthesis I (animals)	0.657144241231329	-0.419851739340894	11	5	0.0124069478908189	403	856	51703,2180,64834,79071,2181	ACSL5,ACSL1,ELOVL1,ELOVL6,ACSL3
HUMAN_PWY-922	mevalonate pathway I	0.657144241231329	-0.419851739340894	11	5	0.0124069478908189	403	856	3157,3422,4598,10654,3156	HMGCS1,IDI1,MVK,PMVK,HMGCR
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	0.657144241231329	-0.419851739340894	11	5	0.0124069478908189	403	856	6241,29922,50484,4832,8382	RRM2,NME7,RRM2B,NME3,NME5
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.686368429223288	-0.376340726587492	9	4	0.00992555831265509	403	856	6241,1635,84284,1841	RRM2,DCTD,NTPCR,DTYMK
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	0.686368429223288	-0.376340726587492	9	4	0.00992555831265509	403	856	8877,22949,56848,130367	SPHK1,PTGR1,SPHK2,SGPP2
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.686368429223288	-0.376340726587492	9	4	0.00992555831265509	403	856	3614,4860,100,4907	IMPDH1,PNP,ADA,NT5E
HUMAN_PWY66-401	tryptophan utilization I	0.717468438329536	-0.332026320706769	41	18	0.0446650124069479	403	856	55191,349565,64802,130013,2639,5447,6818,23057,8564,8942,1548,23498,15,4128,445329,125061,224,1644	NADSYN1,NMNAT3,NMNAT1,ACMSD,GCDH,POR,SULT1A3,NMNAT2,KMO,KYNU,CYP2A6,HAAO,AANAT,MAOA,SULT1A4,AFMID,ALDH3A2,DDC
HUMAN_PWY-5328	superpathway of methionine degradation	0.72004672738125	-0.328439169937269	14	6	0.0148883374689826	403	856	27430,875,2805,6821,4594,594	MAT2B,CBS,GOT1,SUOX,MUT,BCKDHB
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	55902	ACSS2
HUMAN_PWY-6012	acyl carrier protein metabolism	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	60496	AASDHPPT
HUMAN_PWY66-411	tetrahydrobiopterin salvage	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	84105	PCBD2
HUMAN_PWY-6076	1,25-dihydroxyvitamin D3 biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	5447	POR
HUMAN_PWY-5331	taurine biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	51380	CSAD
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis III	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	189	AGXT
HUMAN_PWY66-381	glucocorticoid biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	1584	CYP11B1
META_PWY66-397	resolvin D biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	240	ALOX5
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2618	GART
META_MALATE-ASPARTATE-SHUTTLE-PWY	aspartate degradation II	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2805	GOT1
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2819	GPD1
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	7378	UPP1
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	1735	DIO3
HUMAN_PWY66-301	catecholamine biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	1644	DDC
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation I	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	4329	ALDH6A1
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	140838	NANP
META_PWY66-381	glucocorticoid biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	1584	CYP11B1
META_PWY-5874	heme degradation	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	3162	HMOX1
HUMAN_PWY6666-1	anandamide degradation	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2166	FAAH
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	55253	TYW1
HUMAN_PWY-6620	guanine and guanosine salvage	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	4860	PNP
META_PWY-6118	glycerol-3-phosphate shuttle	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2819	GPD1
HUMAN_PWY-5686	UMP biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	790	CAD
HUMAN_PWY66-397	resolvin D biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	240	ALOX5
HUMAN_PWY66-14	MAP kinase cascade	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2048	EPHB2
HUMAN_PWY-5340	sulfate activation for sulfonation	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	9061	PAPSS1
META_PWY-5766	glutamate degradation X	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2747	GLUD2
HUMAN_PWY-5766	glutamate degradation X	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2747	GLUD2
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis II	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2747	GLUD2
HUMAN_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	57107	PDSS2
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	1735	DIO3
META_GLUTAMATE-SYN2-PWY	glutamate biosynthesis II	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2747	GLUD2
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	57107	PDSS2
META_SER-GLYSYN-PWY	superpathway of serine and glycine biosynthesis I	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	6470	SHMT1
HUMAN_ASPARAGINE-DEG1-PWY	asparagine degradation I	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	374569	ASPG
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2618	GART
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	55907	CMAS
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2805	GOT1
META_PWY-5661	GDP-glucose biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	2645	GCK
META_PWY-6145	superpathway of sialic acid and CMP-sialic acid biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	140838	NANP
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	1735	DIO3
META_PWY66-388	fatty acid alpha-oxidation III	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	224	ALDH3A2
HUMAN_GLYSYN-PWY	glycine biosynthesis I	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	6470	SHMT1
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	197258	FUK
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	7378	UPP1
META_PWY-7343	UDP-glucose biosynthesis	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	7360	UGP2
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.720232825044854	-0.328180751126384	2	1	0.00248138957816377	403	856	1735	DIO3
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	3145,210,5498	HMBS,ALAD,PPOX
HUMAN_CITRULBIO-PWY	citrulline biosynthesis	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	384,440,4942	ARG2,ASNS,OAT
META_PWY-7224	purine deoxyribonucleosides salvage	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	2987,1716,1633	GUK1,DGUOK,DCK
HUMAN_PWY-6318	phenylalanine degradation IV	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	4128,2805,224	MAOA,GOT1,ALDH3A2
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	64768,9807,117283	IPPK,IP6K1,IP6K3
META_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation III (eukaryotic)	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	8564,130013,23498	KMO,ACMSD,HAAO
HUMAN_PWY-5920	heme biosynthesis	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	3145,210,5498	HMBS,ALAD,PPOX
HUMAN_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	2997,2632,7360	GYS1,GBE1,UGP2
META_PWY-6369	inositol pyrophosphates biosynthesis	0.723671147496804	-0.323418205948466	7	3	0.00744416873449132	403	856	64768,9807,117283	IPPK,IP6K1,IP6K3
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.728917807186068	-0.316194300674152	21	9	0.0223325062034739	403	856	6241,790,84284,1841,29922,50484,4832,8382,1503	RRM2,CAD,NTPCR,DTYMK,NME7,RRM2B,NME3,NME5,CTPS1
META_PWY-6857	retinol biosynthesis	0.746398918240175	-0.292495078753141	12	5	0.0124069478908189	403	856	5948,9249,9227,157506,1066	RBP2,DHRS3,LRAT,RDH10,CES1
HUMAN_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.746398918240175	-0.292495078753141	12	5	0.0124069478908189	403	856	51703,9415,2180,2181,142827	ACSL5,FADS2,ACSL1,ACSL3,C10orf129
META_PWY-6030	serotonin and melatonin biosynthesis	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	1644,15	DDC,AANAT
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	1633,7084	DCK,TK2
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	1644,15	DDC,AANAT
META_PWY66-367	ketogenesis	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	3157,622	HMGCS1,BDH1
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	5161,5160	PDHA2,PDHA1
META_PWY66-201	nicotine degradation IV	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	1548,2328	CYP2A6,FMO3
HUMAN_PWY66-21	ethanol degradation II	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	55902,224	ACSS2,ALDH3A2
HUMAN_PWY66-387	fatty acid alpha-oxidation II	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	2180,224	ACSL1,ALDH3A2
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	9945,6675	GFPT2,UAP1
HUMAN_PWY-5030	histidine degradation III	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	10841,131669	FTCD,UROC1
META_PWY-4921	protein citrullination	0.774586449358604	-0.255426005782098	5	2	0.00496277915632754	403	856	51702,11240	PADI3,PADI2
HUMAN_PWY66-402	phenylalanine utilization	0.777431644851713	-0.251759555383075	10	4	0.00992555831265509	403	856	4128,2805,224,1644	MAOA,GOT1,ALDH3A2,DDC
HUMAN_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	0.777431644851713	-0.251759555383075	10	4	0.00992555831265509	403	856	10570,7378,1807,1809	DPYSL4,UPP1,DPYS,DPYSL3
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	0.814919335282046	-0.204666145753688	8	3	0.00744416873449132	403	856	166929,55627,6609	SGMS2,SMPD4,SMPD1
HUMAN_PWY-7205	CMP phosphorylation	0.814919335282046	-0.204666145753688	8	3	0.00744416873449132	403	856	29922,4832,8382	NME7,NME3,NME5
HUMAN_PWY-4081	glutathione redox reactions I	0.814919335282046	-0.204666145753688	8	3	0.00744416873449132	403	856	2878,2876,2879	GPX3,GPX1,GPX4
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	0.814919335282046	-0.204666145753688	8	3	0.00744416873449132	403	856	3614,6241,2987	IMPDH1,RRM2,GUK1
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.817146997527611	-0.201936276772025	13	5	0.0124069478908189	403	856	6241,790,84284,1841,1503	RRM2,CAD,NTPCR,DTYMK,CTPS1
HUMAN_PWY-6313	serotonin degradation	0.846167304065119	-0.167038179985414	11	4	0.00992555831265509	403	856	4128,445329,224,6818	MAOA,SULT1A4,ALDH3A2,SULT1A3
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.846167304065119	-0.167038179985414	11	4	0.00992555831265509	403	856	1841,29922,4832,8382	DTYMK,NME7,NME3,NME5
HUMAN_PWY66-399	gluconeogenesis	0.84798314964396	-0.164894514090536	16	6	0.0148883374689826	403	856	5224,5091,92579,5230,669,226	PGAM2,PC,G6PC3,PGK1,BPGM,ALDOA
META_FAO-PWY	fatty acid beta-oxidation I	0.84798314964396	-0.164894514090536	16	6	0.0148883374689826	403	856	51703,2180,3033,30,23305,2181	ACSL5,ACSL1,HADH,ACAA1,ACSL6,ACSL3
META_PWY66-399	gluconeogenesis III	0.84798314964396	-0.164894514090536	16	6	0.0148883374689826	403	856	5224,5091,92579,5230,669,226	PGAM2,PC,G6PC3,PGK1,BPGM,ALDOA
HUMAN_PROPIONMET-PWY	methylmalonyl pathway	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	4594	MUT
META_ADENOSYLHOMOCYSCAT-PWY	methionine salvage II (mammalia)	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	4548	MTR
META_PWY-5664	tetrahydrobiopterin biosynthesis II	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	5805	PTS
HUMAN_HISHP-PWY	histidine degradation VI	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	131669	UROC1
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	4860	PNP
META_PWY66-392	lipoxin biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	240	ALOX5
HUMAN_PROSYN-PWY	proline biosynthesis I	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	65263	PYCRL
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	4548	MTR
META_PWY66-301	catecholamine biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	1644	DDC
HUMAN_SER-GLYSYN-PWY-1	serine and glycine biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	6470	SHMT1
HUMAN_METHIONINE-DEG1-PWY	methionine degradation I (to homocysteine)	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	27430	MAT2B
META_PWY-0	putrescine degradation III	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	224	ALDH3A2
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	64768	IPPK
HUMAN_PWY-6032	cardenolide biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	6716	SRD5A2
META_PWY-5663	tetrahydrobiopterin biosynthesis I	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	5805	PTS
HUMAN_GLUTAMINDEG-PWY	glutamine degradation I	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	440	ASNS
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	5805	PTS
META_PHENYLALANINE-DEG1-PWY	phenylalanine degradation I (aerobic)	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	5092	PCBD1
META_PWY-7177	UTP and CTP dephosphorylation II	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	1503	CTPS1
META_PWY-3661	glycine betaine degradation	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	6470	SHMT1
META_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	5498	PPOX
HUMAN_PWY-5966	fatty acid biosynthesis initiation II	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	2194	FASN
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	10007	GNPDA1
META_PWY-4202	arsenate detoxification I (glutaredoxin)	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	4860	PNP
HUMAN_COA-PWY	coenzyme A biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	60490	PPCDC
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	5498	PPOX
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation I	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	84105	PCBD2
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	27430	MAT2B
HUMAN_PWY-5453	methylglyoxal degradation III	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	57016	AKR1B10
META_PWY66-221	nicotine degradation III	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	1548	CYP2A6
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	10229	COQ7
HUMAN_PWY66-392	lipoxin biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	240	ALOX5
HUMAN_PWY-4261	glycerol degradation I	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	256356	GK5
HUMAN_PWY-7283	wybutosine biosynthesis	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	55253	TYW1
HUMAN_PWY-6608	guanosine nucleotides degradation	0.852254103158866	-0.159870553474259	3	1	0.00248138957816377	403	856	4860	PNP
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.854774465021929	-0.156917628442473	21	8	0.0198511166253102	403	856	159,204,10476,521,498,267020,158067,122622	ADSS,AK2,ATP5H,ATP5I,ATP5A1,ATP5L2,AK8,ADSSL1
META_PWY-5972	stearate biosynthesis I (animals)	0.861664933437673	-0.148888792194066	6	2	0.00496277915632754	403	856	2180,79071	ACSL1,ELOVL6
META_PWY-6342	noradrenaline and adrenaline degradation	0.861664933437673	-0.148888792194066	6	2	0.00496277915632754	403	856	1312,224	COMT,ALDH3A2
HUMAN_PWY66-161	oxidative ethanol degradation III	0.861664933437673	-0.148888792194066	6	2	0.00496277915632754	403	856	55902,224	ACSS2,ALDH3A2
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.861664933437673	-0.148888792194066	6	2	0.00496277915632754	403	856	1633,7084	DCK,TK2
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.871091592055535	-0.13800815030405	14	5	0.0124069478908189	403	856	790,29922,4832,8382,1503	CAD,NME7,NME3,NME5,CTPS1
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	0.879194788314134	-0.128748803669468	9	3	0.00744416873449132	403	856	6241,84284,1841	RRM2,NTPCR,DTYMK
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.891354896674253	-0.115012618051084	17	6	0.0148883374689826	403	856	1841,29922,1633,4832,8382,7084	DTYMK,NME7,DCK,NME3,NME5,TK2
HUMAN_PWY-6857	retinol biosynthesis	0.891354896674253	-0.115012618051084	17	6	0.0148883374689826	403	856	5948,3990,9249,9227,157506,1066	RBP2,LIPC,DHRS3,LRAT,RDH10,CES1
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	0.896051496981204	-0.109757393349412	12	4	0.00992555831265509	403	856	29922,4832,8382,1503	NME7,NME3,NME5,CTPS1
HUMAN_FAO-PWY	fatty acid beta-oxidation I	0.910915772529513	-0.0933048420563142	15	5	0.0124069478908189	403	856	51703,2180,3033,23305,2181	ACSL5,ACSL1,HADH,ACSL6,ACSL3
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.916862447817028	-0.0867978203577132	7	2	0.00496277915632754	403	856	790,1503	CAD,CTPS1
HUMAN_LEU-DEG2-PWY	leucine degradation I	0.916862447817028	-0.0867978203577132	7	2	0.00496277915632754	403	856	64087,56922	MCCC2,MCCC1
HUMAN_PWY-5130	2-oxobutanoate degradation I	0.916862447817028	-0.0867978203577132	7	2	0.00496277915632754	403	856	4594,594	MUT,BCKDHB
META_PWY66-368	ketolysis	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	622	BDH1
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	594	BCKDHB
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	224	ALDH3A2
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	7378	UPP1
HUMAN_PWY-6117	spermine and spermidine degradation I	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	6303	SAT1
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	594	BCKDHB
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	5160	PDHA1
HUMAN_PWY-5177	glutaryl-CoA degradation	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	2639	GCDH
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	1503	CTPS1
HUMAN_PWY66-367	ketogenesis	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	622	BDH1
META_PWY66-378	androgen biosynthesis	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	6716	SRD5A2
META_PWY-6398	melatonin degradation I	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	5447	POR
META_VALDEG-PWY	valine degradation I	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	594	BCKDHB
META_PWY-6318	phenylalanine degradation IV (mammalian, via side chain)	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	224	ALDH3A2
HUMAN_PWY-4921	protein citrullination	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	51702	PADI3
META_PWY-6402	superpathway of melatonin degradation	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	5447	POR
META_PWY-5130	2-oxobutanoate degradation I	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	594	BCKDHB
META_PWY-6608	guanosine nucleotides degradation III	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	4860	PNP
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	2805	GOT1
META_PWY-6061	bile acid biosynthesis, neutral pathway	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	5447	POR
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	7296	TXNRD1
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	2194	FASN
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	10007	GNPDA1
META_PWY66-387	fatty acid alpha-oxidation II	0.922056678107331	-0.0811485843134869	4	1	0.00248138957816377	403	856	224	ALDH3A2
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.922807564085325	-0.0803345558312989	10	3	0.00744416873449132	403	856	1841,1633,7084	DTYMK,DCK,TK2
META_PWY66-398	TCA cycle VIII (metazoan)	0.939521510206568	-0.0623845650138441	16	5	0.0124069478908189	403	856	6390,4967,6391,1743,2271	SDHB,OGDH,SDHC,DLST,FH
HUMAN_PWY66-398	TCA cycle	0.939521510206568	-0.0623845650138441	16	5	0.0124069478908189	403	856	6390,4967,6391,1743,2271	SDHB,OGDH,SDHC,DLST,FH
HUMAN_PWY-4061	glutathione-mediated detoxification I	0.947310550467453	-0.0541283087537669	19	6	0.0148883374689826	403	856	2678,2954,2941,2950,4259,290	GGT1,GSTZ1,GSTA4,GSTP1,MGST3,ANPEP
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	0.950843485330722	-0.0504058090237164	8	2	0.00496277915632754	403	856	1548,57016	CYP2A6,AKR1B10
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	0.951547661594822	-0.049665502491699	11	3	0.00744416873449132	403	856	4128,1312,224	MAOA,COMT,ALDH3A2
HUMAN_LIPAS-PWY	triacylglycerol degradation	0.951547661594822	-0.049665502491699	11	3	0.00744416873449132	403	856	9388,3990,57104	LIPG,LIPC,PNPLA2
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	0.958924235299185	-0.0419432110787035	5	1	0.00248138957816377	403	856	6241	RRM2
HUMAN_PWY66-368	ketolysis	0.958924235299185	-0.0419432110787035	5	1	0.00248138957816377	403	856	622	BDH1
META_TYRFUMCAT-PWY	tyrosine degradation I	0.958924235299185	-0.0419432110787035	5	1	0.00248138957816377	403	856	2954	GSTZ1
HUMAN_TYRFUMCAT-PWY	tyrosine degradation I	0.958924235299185	-0.0419432110787035	5	1	0.00248138957816377	403	856	2954	GSTZ1
HUMAN_PWY66-241	bupropion degradation	0.958924235299185	-0.0419432110787035	5	1	0.00248138957816377	403	856	1548	CYP2A6
HUMAN_PWY-6166	calcium transport I	0.958924235299185	-0.0419432110787035	5	1	0.00248138957816377	403	856	489	ATP2A3
META_PWY-5327	superpathway of lysine degradation	0.958924235299185	-0.0419432110787035	5	1	0.00248138957816377	403	856	35	ACADS
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.958924235299185	-0.0419432110787035	5	1	0.00248138957816377	403	856	1841	DTYMK
HUMAN_PWY-6402	superpathway of melatonin degradation	0.970046383136312	-0.0304113909616359	12	3	0.00744416873449132	403	856	4128,1548,5447	MAOA,CYP2A6,POR
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.971314541623792	-0.0291049273858161	9	2	0.00496277915632754	403	856	54344,29929	DPM3,ALG6
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis I	0.978376095676123	-0.0218611269639348	6	1	0.00248138957816377	403	856	56994	CHPT1
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	0.978376095676123	-0.0218611269639348	6	1	0.00248138957816377	403	856	6241	RRM2
META_ILEUDEG-PWY	isoleucine degradation I	0.978376095676123	-0.0218611269639348	6	1	0.00248138957816377	403	856	594	BCKDHB
HUMAN_PWY66-378	androgen biosynthesis	0.978376095676123	-0.0218611269639348	6	1	0.00248138957816377	403	856	6716	SRD5A2
META_PWY-7176	UTP and CTP de novo biosynthesis	0.978376095676123	-0.0218611269639348	6	1	0.00248138957816377	403	856	1503	CTPS1
HUMAN_VALDEG-PWY	valine degradation I	0.981724249056819	-0.0184448155020228	13	3	0.00744416873449132	403	856	26275,4329,594	HIBCH,ALDH6A1,BCKDHB
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.981724249056819	-0.0184448155020228	13	3	0.00744416873449132	403	856	3295,5447,80270	HSD17B4,POR,HSD3B7
META_PWY-6872	retinoate biosynthesis I	0.988628370322915	-0.0114367810469226	7	1	0.00248138957816377	403	856	220	ALDH1A3
HUMAN_PWY-5994	palmitate biosynthesis I (animals)	0.988628370322915	-0.0114367810469226	7	1	0.00248138957816377	403	856	2194	FASN
HUMAN_PWY-6398	melatonin degradation I	0.990528758104042	-0.0095163793386652	11	2	0.00496277915632754	403	856	1548,5447	CYP2A6,POR
HUMAN_PWY66-201	nicotine degradation IV	0.990528758104042	-0.0095163793386652	11	2	0.00496277915632754	403	856	1548,2328	CYP2A6,FMO3
HUMAN_PWY66-221	nicotine degradation III	0.994026211038439	-0.00599170341926246	8	1	0.00248138957816377	403	856	1548	CYP2A6
HUMAN_PWY-5996	oleate biosynthesis II (animals)	0.994026211038439	-0.00599170341926246	8	1	0.00248138957816377	403	856	9415	FADS2
HUMAN_PWY-6872	retinoate biosynthesis I	0.994026211038439	-0.00599170341926246	8	1	0.00248138957816377	403	856	220	ALDH1A3
HUMAN_ILEUDEG-PWY	isoleucine degradation I	0.999764815544546	-0.000235212115655414	13	1	0.00248138957816377	403	856	594	BCKDHB
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
HUMAN_PWY0-662	PRPP biosynthesis	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-4041	gamma-glutamyl cycle	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation II	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-5030	histidine degradation III	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_LYSINE-DEG1-PWY	lysine degradation II	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
HUMAN_PWY-6482	diphthamide biosynthesis	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PROSYN-PWY	proline biosynthesis I	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-5177	glutaryl-CoA degradation	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-4061	glutathione-mediated detoxification I	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-5453	methylglyoxal degradation III	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
HUMAN_PWY-1801	formaldehyde oxidation II (glutathione-dependent)	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-6535	4-aminobutyrate degradation I	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
HUMAN_PWY-5137	fatty acid beta-oxidation III (unsaturated, odd number)	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-6370	ascorbate recycling (cytosolic)	0.99999999999173	-8.27010682158402e-12	2	0	0	403	856
META_PWY-5996	oleate biosynthesis II (animals and fungi)	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
HUMAN_PWY-6875	retinoate biosynthesis II	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
HUMAN_PWY-6100	L-carnitine biosynthesis	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
META_PWY-6875	retinoate biosynthesis II	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
META_PWY-5451	acetone degradation I (to methylglyoxal)	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
HUMAN_PWY-6181	histamine degradation	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle pathway	0.999999999998427	-1.5725754032303e-12	3	0	0	403	856
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-6483	ceramide degradation	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-5754-1	4-hydroxybenzoate biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-6134	tyrosine biosynthesis IV	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY0-522	lipoate salvage I	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-6377	alpha-tocopherol degradation	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_BGALACT-PWY	lactose degradation III	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-7299	progesterone biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-6111	mitochondrial L-carnitine shuttle pathway	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-4101	sorbitol degradation I	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_NADPHOS-DEPHOS-PWY	NAD phosphorylation and dephosphorylation	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-7299	progesterone biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-6173	histamine biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation II	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY66-241	bupropion degradation	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_HISHP-PWY	histidine degradation VI	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY0-1021	alanine biosynthesis III	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_MANNCAT-PWY	D-mannose degradation	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-6535	4-aminobutyrate degradation I	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY0-662	PRPP biosynthesis I	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_CITRULLINE-DEG-PWY	citrulline degradation	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-6377	alpha-tocopherol degradation	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY0-1021	alanine biosynthesis III	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_GLUDEG-I-PWY	glutamate degradation III (via 4-aminobutyrate)	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-6134	tyrosine biosynthesis IV	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_PWY-2161B	glutamate removal from folates	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation I	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-6181	histamine degradation	1.00000000000048	4.8105963657008e-13	1	0	0	403	856
META_PWY-7205	CMP phosphorylation	1.00000000000394	3.93895333017369e-12	4	0	0	403	856
META_GLUDEG-I-PWY	glutamate degradation III (via 4-aminobutyrate)	1.00000000000394	3.93895333017369e-12	4	0	0	403	856
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000394	3.93895333017369e-12	4	0	0	403	856
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000001147	1.14660121675048e-11	6	0	0	403	856